pubmed.ncbi.nlm.nih.gov

[Gene mutation and myelodysplastic syndromes with ring sideroblast excess] - PubMed

️Invalid Date

Review

[Gene mutation and myelodysplastic syndromes with ring sideroblast excess]

[Article in Chinese]

Fan-Kai Meng et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Aug.

Abstract

Myelodysplastic syndromes (MDS) are heterogeneous clonal hematopoietic stem cell disorders with different mechanisms and diverse prognosis. The excess of ring sideroblasts (RS) is an important presentation MDS, but the mechanisms of RS appearance are obscure and the treatment of MDS-RS is intractable. Splicing factors play a very important role in the maturation process of eucaryon mRNA, recent studies indicate that there is a significant causal relationship between splicing factor 3B subunit 1 (SF3B1) mutation and the presence of ring sideroblasts. Lucubrating the downstream molecular of the mutated SF3B1 can facilitate exploring the mechanisms and new therapeutic strategies of MDS-RS.

PubMed Disclaimer

Similar articles

SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y, Li X, Chang C, Xu F, He Q, Guo J, Tao Y, Liu Y, Liu L, Shi W. Zhu Y, et al. Leuk Res. 2016 May;44:8-16. doi: 10.1016/j.leukres.2016.02.011. Epub 2016 Feb 27. Leuk Res. 2016. PMID: 26970172
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jädersten M, Jansson M, Elena C, Gallì A, Walldin G, Della Porta MG, Raaschou-Jensen K, Travaglino E, Kallenbach K, Pietra D, Ljungström V, Conte S, Boveri E, Invernizzi R, Rosenquist R, Campbell PJ, Cazzola M, Hellström Lindberg E. Malcovati L, et al. Blood. 2015 Jul 9;126(2):233-41. doi: 10.1182/blood-2015-03-633537. Epub 2015 May 8. Blood. 2015. PMID: 25957392 Free PMC article.
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts.
Visconte V, Tabarroki A, Zhang L, Parker Y, Hasrouni E, Mahfouz R, Isono K, Koseki H, Sekeres MA, Saunthararajah Y, Barnard J, Lindner D, Rogers HJ, Tiu RV. Visconte V, et al. J Hematol Oncol. 2014 Dec 7;7:89. doi: 10.1186/s13045-014-0089-x. J Hematol Oncol. 2014. PMID: 25481243 Free PMC article.
Refractory anemia with ring sideroblasts.
Malcovati L, Cazzola M. Malcovati L, et al. Best Pract Res Clin Haematol. 2013 Dec;26(4):377-85. doi: 10.1016/j.beha.2013.09.005. Epub 2013 Oct 1. Best Pract Res Clin Haematol. 2013. PMID: 24507814 Review.
Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
Patnaik MM, Tefferi A. Patnaik MM, et al. Am J Hematol. 2015 Jun;90(6):549-59. doi: 10.1002/ajh.24038. Am J Hematol. 2015. PMID: 25899435 Review.

Cited by

[1q21 abnormality associated with multiple primary malignant tumor: two cases report and literatures review].
Zhang QQ, Tang XW, Wang AJ, Xue SL, Tian XP, Wang TJ, Yin J, Wu DP. Zhang QQ, et al. Zhonghua Xue Ye Xue Za Zhi. 2017 Mar 14;38(3):247-248. doi: 10.3760/cma.j.issn.0253-2727.2017.03.015. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28395452 Free PMC article. Review. Chinese. No abstract available.

[Gene mutation and myelodysplastic syndromes with ring sideroblast excess] - PubMed